NCT01711047

Brief Summary

The optimal strategy for catheter ablation of persistent atrial fibrillation is not clearly defined. This study investigates if Complex Fractionated Atrial Electrogram (CFAE) ablation in addition to pulmonary vein isolation and linear ablations improves single procedural success rate over a 12 month follow up period.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2010

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2010

Completed
2.6 years until next milestone

First Submitted

Initial submission to the registry

October 12, 2012

Completed
10 days until next milestone

First Posted

Study publicly available on registry

October 22, 2012

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2013

Completed
Last Updated

October 12, 2017

Status Verified

October 1, 2017

Enrollment Period

3.4 years

First QC Date

October 12, 2012

Last Update Submit

October 11, 2017

Conditions

Keywords

catheter ablationatrial fibrillationpulmonary vein isolationlinear ablationCFAE ablation

Outcome Measures

Primary Outcomes (1)

  • Single procedural success rate (free from AF off anti-arrhythmic drugs)

    12 MONTHS

Secondary Outcomes (6)

  • Multiple procedure success rate

    12 months after last ablation

  • Complication rate

    30 days of procedure

  • Percentage of AF termination

    Time 0

  • recurrence of atrial fibrillation or organised atrial tachycardia

    12 months after the last procedure

  • Ablation time

    Time 0

  • +1 more secondary outcomes

Study Arms (2)

PVI + Linear ablation

ACTIVE COMPARATOR

Arm A: patients have PVI and roof and mitral isthmus lines

Procedure: Radiofrequency catheter Ablation

PVI + linear ablation + CFAE

ACTIVE COMPARATOR

Arm B: patients have PVI + roof and mitral isthmus lines and CFAE ablation

Procedure: Radiofrequency catheter ablation

Interventions

In this arm, catheter ablation would be performed in the left atrium and would include pulmonary vein isolation and linear ablations (roof and mitral isthmus lines)

PVI + Linear ablation

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • persistent atrial fibrillation

You may not qualify if:

  • previous catheter or surgical ablation for atrial fibrillation
  • pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Royal Bournemouth Hospital

Bournemouth, United Kingdom

Location

John Radcliffe Hospital

Oxford, OX3 9DU, United Kingdom

Location

Related Publications (1)

  • Wong KC, Paisey JR, Sopher M, Balasubramaniam R, Jones M, Qureshi N, Hayes CR, Ginks MR, Rajappan K, Bashir Y, Betts TR. No Benefit of Complex Fractionated Atrial Electrogram Ablation in Addition to Circumferential Pulmonary Vein Ablation and Linear Ablation: Benefit of Complex Ablation Study. Circ Arrhythm Electrophysiol. 2015 Dec;8(6):1316-24. doi: 10.1161/CIRCEP.114.002504. Epub 2015 Aug 17.

MeSH Terms

Conditions

Atrial Fibrillation

Interventions

Catheter Ablation

Condition Hierarchy (Ancestors)

Arrhythmias, CardiacHeart DiseasesCardiovascular DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Radiofrequency AblationRadiofrequency TherapyTherapeuticsAblation TechniquesSurgical Procedures, Operative

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 12, 2012

First Posted

October 22, 2012

Study Start

March 1, 2010

Primary Completion

August 1, 2013

Study Completion

August 1, 2013

Last Updated

October 12, 2017

Record last verified: 2017-10

Locations